CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 
 

AMGN's Net Income Growth by Quarter and Year

Amgen Inc 's Net Income results by quarter and year




AMGN Net Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 1,616.00 1,899.00 1,615.00
III Quarter September - 2,143.00 1,884.00 2,021.00
II Quarter June 1,379.00 1,317.00 464.00 1,803.00
I Quarter March 2,841.00 1,476.00 1,646.00 1,825.00
FY   4,220.00 6,552.00 5,893.00 7,264.00



AMGN Net Income second quarter 2023 Y/Y Growth Comment
Amgen Inc reported Net Income growth of 4.71% year on year in the second quarter 2023, to $ 1,379.00 millions, this is lower than Amgen Inc 's recent average Net Income increase of 18.8%.

Looking into second quarter 2023 results within Biotechnology & Pharmaceuticals industry 4 other companies have achieved higher Net Income growth. While Amgen Inc ' s Net Income increase of 4.71% ranks overall at the positon no. 643 in the second quarter 2023.




AMGN Net Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -14.9 % 17.59 % -5.17 %
III Quarter September - 13.75 % -6.78 % 2.69 %
II Quarter June 4.71 % 183.84 % -74.27 % -17.26 %
I Quarter March 92.48 % -10.33 % -9.81 % -8.38 %
FY   - 11.18 % -18.87 % -7.37 %

Financial Statements
Amgen Inc 's second quarter 2023 Net Income $ 1,379.00 millions AMGN's Income Statement
Amgen Inc 's second quarter 2022 Net Income $ 1,317.00 millions Quarterly AMGN's Income Statement
New: More AMGN's historic Net Income Growth >>


AMGN Net Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -24.59 % 0.8 % -20.09 %
III Quarter September - 62.72 % 306.03 % 12.09 %
II Quarter June -51.46 % -10.77 % -71.81 % -1.21 %
I Quarter March 75.8 % -22.27 % 1.92 % 7.16 %
FY (Year on Year)   - 11.18 % -18.87 % -7.37 %




Net Income second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #5
Healthcare Sector #37
Overall #643

Net Income Y/Y Growth Statistics
High Average Low
324.15 % 18.8 % -74.37 %
(Dec 31 2018)   (Dec 31 2017)
Net Income second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #5
Healthcare Sector #37
Overall #643
Net Income Y/Y Growth Statistics
High Average Low
324.15 % 18.8 % -74.37 %
(Dec 31 2018)   (Dec 31 2017)

Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Amgen Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
7771.43 % 112.93 % -98.6 %
(Sep. 30, 2006)  


AMGN's II. Quarter Q/Q Net Income Comment
In the II. Quarter 2023 Amgen Inc disclosed fall in Net Income from the previous quarter by -51.46% to $ 1,379.00 millions, from $ 2,841.00 millions released in the previous quarter.

When you analyse present shortcoming at the II. Quarter, you must assume, that usually II. Quarter Net Income emerge softer in contrast to the quarter before

Within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher Net Income quarter on quarter growth. While Amgen Inc 's Net Income growth quarter on quarter, overall rank is 1515.


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #8
Healthcare Sector #98
Overall #1515
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #8
Healthcare Sector #98
Overall #1515
Net Income Q/Q Growth Statistics
High Average Low
7771.43 % 112.93 % -98.6 %
(Sep. 30, 2006)  


AMGN's II. Quarter Q/Q Net Income Comment
In the II. Quarter 2023 Amgen Inc reported fall in Net Income sequentially by -51.46% to $ 1,379.00 millions, from $ 2,841.00 millions achived in the previous reporting period.

This is not huge concern, as Amgen Inc 's Net Income frequently gravitate to dip in the II. Quarter.

Within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher Net Income quarter on quarter growth. While Amgen Inc 's Net Income growth quarter on quarter, overall rank is 1515.


Amgen Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Net Income 12 Months Ending $ 7,979.00 $ 7,917.00 $ 6,552.00 $ 6,835.00 $ 6,576.00
Y / Y Net Income Growth (TTM) 21.34 % 38.34 % 11.18 % 21.86 % 14.44 %
Year on Year Net Income Growth Overall Ranking # 739 # 234 # 1157 # 448 # 967
Seqeuential Net Income Change (TTM) 0.78 % 20.83 % -4.14 % 3.94 % 14.9 %
Seq. Net Income Growth (TTM) Overall Ranking # 732 # 184 # 799 # 514 # 742




Cumulative Net Income growth Comment
Assuming the Amgen Inc 's fiscal year would have ended in Jun 30 2023, Amgen Inc would have reprted above average annual Net Income rise of 21.34% year on year, of $ 7,979 millions.
This marks a slow-down of the companys growth trends and from the 38.34% improvement in Mar 31 2023.

In the Healthcare sector 39 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 234 to 739.

Net Income TTM Q/Q Growth Statistics
High Average Low
324.15 %
18.8 %
-74.37 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 5
Healthcare Sector # 40
Overall # 739

Net Income TTM Y/Y Growth Statistics
High Average Low
324.15 %
18.8 %
-74.37 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 40
S&P 500 # 732
Cumulative Net Income growth Comment
Assuming the Amgen Inc 's fiscal year would have ended in Jun 30 2023, Amgen Inc would have reprted above average annual Net Income rise of 21.34% year on year, of $ 7,979 millions.
This marks a slow-down of the companys growth trends and from the 38.34% improvement in Mar 31 2023.

In the Healthcare sector 39 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 234 to 739.

Net Income TTM Q/Q Growth Statistics
High Average Low
324.15 %
18.8 %
-74.37 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 5
Healthcare Sector # 40
Overall # 739

Net Income TTM Y/Y Growth Statistics
High Average Low
324.15 %
18.8 %
-74.37 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 40
S&P 500 # 732




Other Net Income Growth
Biotechnology & Pharmaceuticals Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
AMGN's Net Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for AMGN's Competitors
Net Income Growth for Amgen Inc 's Suppliers
Net Income Growth for AMGN's Customers

You may also want to know
AMGN's Annual Growth Rates AMGN's Profitability Ratios AMGN's Asset Turnover Ratio AMGN's Dividend Growth
AMGN's Roe AMGN's Valuation Ratios AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio
AMGN's Roa AMGN's Inventory Turnover Ratio AMGN's Growth Rates AMGN's Dividend Comparisons



Companies with similar Net Income improvement for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Jun 30 2023
Assertio Holdings inc 8.12%$ 8.118 millions
Universal Health Services Inc 6.63%$ 6.626 millions
Globus Medical Inc 5.72%$ 5.719 millions
Radnet Inc 5.26%$ 5.256 millions
Amgen Inc 4.71%$ 4.708 millions
Pediatrix Medical Group Inc 4.22%$ 4.223 millions
Boston Scientific Corporation3.85%$ 3.846 millions
Organon and Co 3.42%$ 3.419 millions
Hca Healthcare Inc 2.39%$ 2.393 millions
Utah Medical Products Inc2.36%$ 2.364 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright Š 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com